Human papillomavirus and natural history of cervical intraepithelial neoplasia : clinical consequences
(Humaan Papillomavirus en het natuurlijk beloop van Cervicale lntraepitheliale Neoplasie: klinische consequenties)
2001-10-10
Doctoral Thesis
| Related Files |
|---|
View PDF Version
(011010_Nobbenhuis, Maria Anna Elisabeth.pdf, 2.7MB) |
|
View PDF Version
(stellingen nobbenhuis.pdf, 0.0MB) |
Cervical cancer is the second most common cancer in women world-wide after breast cancer. Each year, there are approximately 437,000 new cases of invasive cancer of the cervix diagnosed and more than 200,000 women die from the disease, 79% of which occur in developing countries. In the Netherlands approximately 715 new cases of cervical cancer are diagnosed each year with an age-standardised incidence rate of 8,6 new cases per 1 00,000 women. The age-standardised mortality rate for the Netherlands has been estimated at 2,4 deaths per 1 00,000 women with a total of 234 deaths reported in 1995. The average age-standardised mortality rate of developing countries is 2,5 f1mes that of industrialised areas.
Dutch Prevention Fund/Zorg Onderzoek Nederland,
Digene,
Cytyc Europe,
3M Pharma Nederland,
Schering Nederland BV,
Ferring BV,
Organon Nederland BV,
Rovers Medical Devices BV,
Werkgroep Cervix Uteri
- women
- cancer
- smear
- month
- study
- cytology
- infection
- lesion
- screening
- hpv testing
- testing
- dyskaryosi
- papillomaviru
- follow-up
- result
- clearance
- treatment
- regression
- hpv clearance
- baseline
